← All trials
NCT01328379
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2011
- Primary completion
- Apr 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 430
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Acorda TherapeuticsLead sponsor
- University of California, DavisOverall official - principal investigator
- Alta Bates Summit Medical CenterOverall official - principal investigator
- Northwestern UniversityOverall official - principal investigator
- University of RochesterOverall official - principal investigator
- Phoenix Neurological Associates, LTDOverall official - principal investigator
- University of PennsylvaniaOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- Oregon Health and Science UniversityOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- Rhode Island HospitalOverall official - principal investigator
- Tufts UniversityOverall official - principal investigator
- Metrolina Medical ResearchOverall official - principal investigator
- Axiom Clinical Research of FloridaOverall official - principal investigator
- Suncoast Neuroscience Associates, Inc.Overall official - principal investigator
- Advanced Neurology SpecialistsOverall official - principal investigator
- Raleigh Neurology AssociatesOverall official - principal investigator
- Neurology Specialists, Inc.Overall official - principal investigator
- Josephson Wallack Munshower Neurology, PCOverall official - principal investigator
- Ruan Neurology Clinical Research CenterOverall official - principal investigator
- Advanced Neurosciences InstituteOverall official - principal investigator
- Iowa Health Des MoinesOverall official - principal investigator
- North Central Neurology Associates, PCOverall official - principal investigator
- Negroski, Stein, Sutherland and Hanes NeurologyOverall official - principal investigator
- Baylor UniversityOverall official - principal investigator
- Department of Veteran AffairsOverall official - principal investigator
- Island Neurological Associates, PCOverall official - principal investigator
- Mercy Multiple Sclerosis Center of Oklahoma Mercy Neuroscience InstituteOverall official - principal investigator
- University of WisconsinOverall official - principal investigator
- The Neurological Institute, PAOverall official - principal investigator
- Altru Health System Research CenterOverall official - principal investigator
- Springfield Neurology Associates, LLCOverall official - principal investigator
- The Multiple Sclerosis Center of Vero BeachOverall official - principal investigator
- Arizona Neurological InstituteOverall official - principal investigator
- Shepherd Center, Inc.Overall official - principal investigator
- Hampton Roads NeurologyOverall official - principal investigator
- Sibyl E. Wray, MD, Neurology, PCOverall official - principal investigator
- Consultants in Neurology Ltd.Overall official - principal investigator
- Unifour Medical Research, LLCOverall official - principal investigator
- Georgetown UniversityOverall official - principal investigator
- Loma Linda UniversityOverall official - principal investigator
- Ohio State UniversityOverall official - principal investigator
- Temple UniversityOverall official - principal investigator
- University of MarylandOverall official - principal investigator
- University of MiamiOverall official - principal investigator
- University of VermontOverall official - principal investigator
- Acorda TherapeuticsStudy director
- University of KansasOverall official - principal investigator
- Pennsylvania State UniversityOverall official - principal investigator
- South Shore Neurologic AssociatesOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- Texas NeurologyOverall official - principal investigator
- Upstate Clinical ResearchOverall official - principal investigator
- West Virginia UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.